外科手术期间轻度低温调节关节整形中的炎症反应和凝血途径:一项随机对照试验
Jun Li1, Tianqun Huo1, Xin Men2
1Department of Orthopedics, Changzhou TCM Hospital Affiliated to Nanjing University of Chinese Medicine, Changzhou, China.
概括
关节整形术期间轻度低温会减少术后的炎症和疼痛,有助于早期恢复. 然而,这种温度管理策略并不能改善接受关节置换手术的患者的长期功能结果.
科学领域:
- 整形外科手术 整形外科手术
- 在外科手术期间的医学.
- 热调节 热调节 热调节
背景情况:
- 关节整形术是关节骨关节炎的常见手术.
- 手术后的并发症,如炎症和疼痛,可能会阻碍康复.
- 轻度低温正在探索缓解这些手术并发症.
研究的目的:
- 为了评估轻度低温对炎症,凝血,疼痛和关节整形术后的功能恢复的影响.
- 在关节置换手术期间比较正常热量和轻度低温的结果.
主要方法:
- 一项前性随机对照试验,涉及100名接受初级关节整形手术的患者.
- 患者被分配到正常热量或轻度低温 (34°C35°C).
- 评估了炎症标志物,凝血概况,疼痛评分和1年功能结果 (特殊手术医院评分).
主要成果:
- 轻度低温显著降低了手术后炎症标志物 (WBC,CRP,ESR,TNF-α,IL-6) 的水平.
- 凝血概况发生变化,在轻度低温组中延长PT和aPTT.
- 早期术后疼痛 (24小时) 在轻度低温下较低,但这种差异减少了7天.
- 两组之间没有观察到1年功能恢复的显著差异.
结论:
- 轻度低温有效地减少外科手术期间的炎症,并在关节整形术期间改变凝血.
- 它可以改善早期的疼痛控制,但不能改善长期的功能恢复.
- 需要进一步的研究来确定轻度低温在骨科手术中的最佳作用.
相关概念视频
Inflammatory Response
16.5K
An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
16.5K
Inflammatory Response II: Inflammatory Exudate and Tissue Repair
7.7K
The immune system's inflammatory response destroys the invading pathogen, permitting the tissue to heal. The changes during the cellular and vascular stages allow exudate formation at the site of inflammation. The inflammatory exudate released from the wound has high protein content and a specific gravity above 1.020.
The typical wound exudate is odorless, transparent, straw-colored, thin, and watery. Exudate, however, can differ depending on the state of wound healing. Likewise, the...
The typical wound exudate is odorless, transparent, straw-colored, thin, and watery. Exudate, however, can differ depending on the state of wound healing. Likewise, the...
7.7K
Inflammatory Response I: Vascular and Cellular
16.3K
The inflammatory response is the body's defense against infection, injury, or irritation from bacteria, trauma, toxins, or heat. Inflammation helps locate and destroy pathogens and remove damaged tissue elements to heal the body. During this initial phase, fluid, blood products, and nutrients migrate to the injured area, resulting in redness, heat, swelling, ache, and loss of function. Moreover, signs of systemic inflammation include fever, increased WBC count, malaise, anorexia, nausea,...
16.3K
Coagulation
1.4K
Colloidal solids are solid particles suspended in solution. They are usually negatively charged, attracting a compact primary layer of positively charged ions, which attract more counterions to form an electrical double layer. Electrostatic repulsion between the charged double layers prevents the particles from colliding, stabilizing the colloids. These solids are often undesirable because they can contain toxins that are difficult to remove. Coagulation is a technique that helps aggregate and...
1.4K
Coagulation
10.4K
The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
10.4K
Clinical Trials: Overview
4.9K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
4.9K


